MORGAN STANLEY - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 128 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2013. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$17,000
-15.0%
86,539
+105.1%
0.00%
Q3 2018$20,000
-92.2%
42,197
-91.7%
0.00%
Q2 2018$256,000
-79.9%
509,550
-6.7%
0.00%
Q1 2018$1,272,000
+3.3%
546,151
+26.0%
0.00%
Q4 2017$1,231,000
-20.2%
433,568
-19.6%
0.00%
Q3 2017$1,542,000
+28.2%
539,140
+10.7%
0.00%
Q2 2017$1,203,000
-67.2%
486,896
-52.1%
0.00%
-100.0%
Q1 2017$3,670,000
-24.9%
1,016,810
-26.3%
0.00%0.0%
Q4 2016$4,884,000
+68.5%
1,379,782
+92.3%
0.00%0.0%
Q3 2016$2,899,000
+13.1%
717,572
+22.9%
0.00%0.0%
Q2 2016$2,563,000
+20.8%
583,913
+4.1%
0.00%0.0%
Q1 2016$2,121,000
-83.2%
561,091
-30.2%
0.00%
-80.0%
Q4 2015$12,611,000
+49.1%
804,358
+0.2%
0.01%
+66.7%
Q3 2015$8,457,000
-61.2%
802,538
-7.2%
0.00%
-62.5%
Q2 2015$21,801,000
-8.4%
864,397
+1.2%
0.01%
-11.1%
Q1 2015$23,809,000
+43.4%
854,262
-6.1%
0.01%
+50.0%
Q4 2014$16,603,000
+65.0%
909,763
+17.2%
0.01%
+50.0%
Q3 2014$10,061,000
-27.4%
776,330
-8.6%
0.00%
-20.0%
Q2 2014$13,860,000
+5.0%
849,296
+13.7%
0.01%
-16.7%
Q1 2014$13,195,000
-14.9%
746,754
+16.6%
0.01%
-14.3%
Q4 2013$15,507,000
-21.9%
640,556
+14.3%
0.01%
-22.2%
Q3 2013$19,855,000
+137.5%
560,358
+4.6%
0.01%
+125.0%
Q2 2013$8,360,000535,5740.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2013
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders